Dexmedetomidine-Ketamine Infusion in Breast Surgeries
Status:
Completed
Trial end date:
2020-08-14
Target enrollment:
Participant gender:
Summary
- This is a prospective randomized double blind controlled study.
- Female patients undergoing radical mastectomy will be included in this stydy where they
will be randomly allocated into;- Control group in which patients will receive
continuous infusion of normal saline.
Dexmedetomidine-Ketamine group which patients will receive continuous infusion of ketamine
and dexmedetomidine.
The intraoperative and postoperative opioid consumption will be measured. Also, the
postoperative pain score and the incidence of chronic pain will be assessed.